Fundz

Lift Therapeutics Appoints Daniel Passeri as Chief Executive Officer

PRIVATESep 23, 2026
New to company · from Cue Biopharma“most recently serving as CEO of Cue Biopharma, where he led the company from inception into clinical development”

Position

Chief Executive Officer

Company

Lift Therapeutics

Daniel Passeri
BiotechnologyHealth CareTherapeutics

Description

Lift Therapeutics has appointed Daniel Passeri, MSc, JD, as Chief Executive Officer. Mr. Passeri succeeds Bo Rode Hansen, who will continue as President and member of the Board of Directors.

Quick answer

Lift Therapeutics Appoints Daniel Passeri as Chief Executive Officer (September 23, 2026).

Who is the new Chief Executive Officer at Lift Therapeutics?
Lift Therapeutics named Daniel Passeri Chief Executive Officer, announced September 23, 2026.
What did Lift Therapeutics announce on September 23, 2026?
Lift Therapeutics has appointed Daniel Passeri, MSc, JD, as Chief Executive Officer. Mr. Passeri succeeds Bo Rode Hansen, who will continue as President and member of the Board of Directors.
Where did Daniel Passeri work before joining Lift Therapeutics?
Daniel Passeri joins from Cue Biopharma.
What does Lift Therapeutics do?
Lift Therapeutics is focused on developing novel cancer immunotherapies.
Which similar companies made leadership changes around the same time?
Corcept (September 23, 2026), MeiraGTx Holdings plc (September 23, 2026), Tivic (September 23, 2026) and Wave Life Sciences (September 22, 2026) also announced leadership changes within 45 days of Lift Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Lift Therapeutics, and when

A new leader at Lift Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Lift Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lift Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lift Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lift Therapeutics

About

Lift Therapeutics is focused on developing novel cancer immunotherapies. The company's innovative iMAN platform utilizes neutrophils to modulate the tumor microenvironment. Lift is transitioning into a clinical-stage cancer therapeutics company. They aim to establish iMANs as a new standard of care for treating cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lift Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lift Therapeutics's next move

Learn about Strategic plan

Lift Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.